SCHEMBL14686367

SCHEMBL14686367

CS(=O)(=O)[CH]c1ccccc1OC(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
PTGES2 Q9H7Z7 1/20 0.45
POLB P06746 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
DRD1 P21728 1/20 0.41
HPGD P15428 3/20 0.40
LMNA P02545 2/20 0.40
SLC22A12 Q96S37 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5696554 0.83 HPGD (0.44) L3MBTL1PTGES2POLBCA12CA1
SCHEMBL27690268 0.78 NFE2L2 (0.50) L3MBTL1CA12CA1CA2CA9
SCHEMBL14686399 0.78 CA12 (0.36) L3MBTL1PTGES2CA12CA1CA2
SCHEMBL14686293 0.78 PTGS1 (0.34) CA12CA1CA2CA9KDM4E
SCHEMBL27704261 0.76 PTGES2 (0.45) L3MBTL1PTGES2SLC22A12GAAALDH1A1
SCHEMBL29538287 0.76 ALDH1A1 (0.55) L3MBTL1PTGES2POLBCA12CA1
SCHEMBL908602 0.76 ALDH1A1 (0.55) L3MBTL1PTGES2POLBCA12CA1
SCHEMBL13012150 0.74 PTGES2 (0.53) L3MBTL1PTGES2POLBCA12CA1
SCHEMBL14686369 0.74 TRPV4 (0.43) DRD1LMNAMAPTSMN1; SMN2NPC1
SCHEMBL14686396 0.74 TRPV4 (0.54) DRD1SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1865940-B1 ALPHA KETOAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2013-02-13 EP claimed